Brantly M - Search Results

1

The Mechanism of Mitochondrial Injury in Alpha-1 Antitrypsin Deficiency Mediated Liver Disease.

Khodayari N, Wang RL, Oshins R, Lu Y, Millett M, Aranyos AM, Mostofizadeh S, Scindia Y, Flagg TO, Brantly M. Khodayari N, et al. Among authors: brantly m. Int J Mol Sci. 2021 Dec 9;22(24):13255. doi: 10.3390/ijms222413255. Int J Mol Sci. 2021. PMID: 34948056 Free PMC article.

2

Molecular basis of alpha-1-antitrypsin deficiency.

Brantly M, Nukiwa T, Crystal RG. Brantly M, et al. Am J Med. 1988 Jun 24;84(6A):13-31. doi: 10.1016/0002-9343(88)90154-4. Am J Med. 1988. PMID: 3289385 Review.

3

Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors.

Song S, Morgan M, Ellis T, Poirier A, Chesnut K, Wang J, Brantly M, Muzyczka N, Byrne BJ, Atkinson M, Flotte TR. Song S, et al. Among authors: brantly m. Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14384-8. doi: 10.1073/pnas.95.24.14384. Proc Natl Acad Sci U S A. 1998. PMID: 9826709 Free PMC article.

4

Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults.

Flotte TR, Brantly ML, Spencer LT, Byrne BJ, Spencer CT, Baker DJ, Humphries M. Flotte TR, et al. Among authors: brantly ml. Hum Gene Ther. 2004 Jan;15(1):93-128. doi: 10.1089/10430340460732490. Hum Gene Ther. 2004. PMID: 14965381 Clinical Trial.

5

Cytotoxic concentrations of alpha-defensins in the lungs of individuals with alpha 1-antitrypsin deficiency and moderate to severe lung disease.

Wencker M, Brantly ML. Wencker M, et al. Among authors: brantly ml. Cytokine. 2005 Oct 7;32(1):1-6. doi: 10.1016/j.cyto.2005.06.003. Cytokine. 2005. PMID: 16137891

6

In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNA.

Cruz PE, Mueller C, Cossette TL, Golant A, Tang Q, Beattie SG, Brantly M, Campbell-Thompson M, Blomenkamp KS, Teckman JH, Flotte TR. Cruz PE, et al. Among authors: brantly m. Lab Invest. 2007 Sep;87(9):893-902. doi: 10.1038/labinvest.3700629. Epub 2007 Jun 25. Lab Invest. 2007. PMID: 17592477 Free article.

7

Human alpha 1-antitrypsin therapy induces fatal anaphylaxis in non-obese diabetic mice.

Lu Y, Parker M, Pileggi A, Zhang B, Choi YK, Molano RD, Wasserfall C, Ricordi C, Inverardi L, Brantly M, Schatz D, Atkinson M, Song S. Lu Y, et al. Among authors: brantly m. Clin Exp Immunol. 2008 Oct;154(1):15-21. doi: 10.1111/j.1365-2249.2008.03721.x. Epub 2008 Aug 28. Clin Exp Immunol. 2008. PMID: 18759852 Free PMC article.

8

Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy.

Brantly ML, Chulay JD, Wang L, Mueller C, Humphries M, Spencer LT, Rouhani F, Conlon TJ, Calcedo R, Betts MR, Spencer C, Byrne BJ, Wilson JM, Flotte TR. Brantly ML, et al. Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16363-8. doi: 10.1073/pnas.0904514106. Epub 2009 Aug 12. Proc Natl Acad Sci U S A. 2009. PMID: 19706466 Free PMC article. Clinical Trial.

9

Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank.

Tonelli AR, Rouhani F, Li N, Schreck P, Brantly ML. Tonelli AR, et al. Int J Chron Obstruct Pulmon Dis. 2009;4:443-52. doi: 10.2147/copd.s8577. Epub 2009 Dec 29. Int J Chron Obstruct Pulmon Dis. 2009. PMID: 20054436 Free PMC article.

10

Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.

Tonelli AR, Brantly ML. Tonelli AR, et al. Ther Adv Respir Dis. 2010 Oct;4(5):289-312. doi: 10.1177/1753465810373911. Epub 2010 Jul 22. Ther Adv Respir Dis. 2010. PMID: 20650978 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page